Astromech buys fellow Colossal spinout Form Bio for $230M in stock
The deal would put Andrew Busey in charge of Astromech AI and technology, giving the $3.8B prediction company Form Bio's genetic medicine design tools.
By Ryan Merket · Published

The deal would put Andrew Busey in charge of Astromech AI and technology, giving the $3.8B prediction company Form Bio's genetic medicine design tools.